HR23B, a biomarker for HDAC inhibitors

HR23B, a biomarker for HDAC inhibitors

<p>As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available. Aberrant acetylation has been strongly linked to tumourigenesis and the modulation of acetylation through targeting histone d...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur:	Khan, OA
Andere auteurs:	La Thangue, NB
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	2013
Onderwerpen:	Pharmacology Tumours Clinical laboratory sciences Medical Sciences Oncology

Gelijkaardige items

Mitochondrial modulators of hypoxia-related pathways in tumours
door: Snell, CE
Gepubliceerd in: (2013)

Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment
door: New, M
Gepubliceerd in: (2014)

Angiogenesis in human lung tumours
door: Ferguson, ML
Gepubliceerd in: (2008)

Risk factors for haemorrhage in patients with haematological malignancies
door: Estcourt, LJ
Gepubliceerd in: (2014)

Regulation of stemness and differentiation in colorectal cancer
door: Gandhi, S
Gepubliceerd in: (2010)

Development of sindbis virus as an oncolytic agent
door: Kueberuwa, GLB
Gepubliceerd in: (2012)

Tumour-stroma interaction in pancreatic cancer
door: Lunardi, S
Gepubliceerd in: (2013)

Targeting EGFR signalling pathway in triple negative breast cancer
door: Albukhari, A
Gepubliceerd in: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
door: Albukhari, A
Gepubliceerd in: (2014)

Characterising the role of circulating immune cells in brain metastasis
door: Balathasan, L
Gepubliceerd in: (2012)

The role of ATF4 in hypoxia-induced cell death in cancer
door: Pike, L, et al.
Gepubliceerd in: (2011)

Combining regulatory angiogenic gene therapy and virotherapy for the treatment of breast cancer
door: Bazan Peregrino, M
Gepubliceerd in: (2007)

Modulating the immune system by amino acid depletion - IDO and beyond
door: Vallius, L
Gepubliceerd in: (2011)

Novel signalling pathways regulating epithelial-mesenchymal transition in bone metastatic prostate cancer
door: Rao, SR
Gepubliceerd in: (2014)

Arginine methylation in the E2F1 pathway
door: Zheng, S
Gepubliceerd in: (2013)

Investigating a role of ASPP2 in the cellular response to infection
door: Lim, Y, et al.
Gepubliceerd in: (2014)

Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
door: Potter, M
Gepubliceerd in: (2014)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
door: Thoma, CMM
Gepubliceerd in: (2011)

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
door: Khan, O, et al.
Gepubliceerd in: (2010)

The role of host microenvironment in the pathogenesis of multiple myeloma
door: Lwin, STS
Gepubliceerd in: (2014)

Targeting polymer coated adenovirus to tumour-associated vasculature
door: Bachtarzi, H
Gepubliceerd in: (2010)

Managing melanoma in the era of personalised therapy: more than one disease
door: Rughani, M, et al.
Gepubliceerd in: (2012)

Loss of chaperone protein in human cancer
door: Adighibe, O
Gepubliceerd in: (2012)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
door: Wijeyekoon, JB
Gepubliceerd in: (2013)

Tolerance in renal transplantation: is mixed chimerism the missing link?
door: Janes, S, et al.
Gepubliceerd in: (2009)

The role of DLL4-NOTCH signalling in endothelial cell metabolism
door: Harjes, U
Gepubliceerd in: (2014)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
door: Jackson, M
Gepubliceerd in: (2013)

The role of HER4 in relation to trastuzumab resistance and prognosis in HER2 positive breast cancer
door: Mohd Nafi, SN
Gepubliceerd in: (2014)

Development of clinical biomarkers of DNA double strand breaks for cancer care
door: Shah, K
Gepubliceerd in: (2012)

Biomarkers of anti-angiogenic therapy in breast cancer
door: Mehta, S
Gepubliceerd in: (2014)

Development of bioreductive inhibitors of checkpoint kinase 1 to target hypoxic tumours
door: Körner, C
Gepubliceerd in: (2015)

Selective targeting of homologous recombination deficiency
door: Zimmer, J
Gepubliceerd in: (2014)

The three methyls: the function and therapeutic potential of histone H3K36 trimethylation
door: Pfister, SX
Gepubliceerd in: (2014)

Impact of TMPRSS2-ERG fusion gene on prostate cancer cell response to chemotherapy, radiotherapy and androgen deprivation therapy
door: Ovtcharov, S
Gepubliceerd in: (2015)

Targeting cell adhesion as a method of sensitising metastatic tumour cells to TRAIL-induced apoptosis
door: Phipps, L
Gepubliceerd in: (2011)

Cortical dynamics subserving visual apparent motion
door: Ahmed, B, et al.
Gepubliceerd in: (2008)

Investigating the endogenous role of human n-acetyltransferase 1, as potential breast cancer biomarker, using chemical biology
door: Laurieri, N
Gepubliceerd in: (2012)

Heterogeneity of tumour response to hypoxia: carbonic anhydrase IX induction defines a subpopulation of hypoxic cells with stem cell properties and drug resistance
door: Ledaki, I
Gepubliceerd in: (2013)

A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
door: New, M, et al.
Gepubliceerd in: (2013)

A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
door: New, M, et al.
Gepubliceerd in: (2013)